Navigation Links
WHRC releases 4 key reports
Date:12/2/2007

ards, and greater institutional capacity to govern the vast Amazon forest region. More than 90 percent of the opportunity costs of forest maintenance could be compensated for a per-ton carbon value of $3, while actually achieving the reduction would be much cheaper: about $1.2 per ton. In the proposed program, all of the regions forest people would double their incomes, and $10 to 80 million per year in fire-related damages would be avoided. These results show that REDD programs will bring substantial benefits to tropical countries that need to be included in evaluations of the economics. For the first time, we have fundamental information and analyses to demonstrate that it is feasible to end carbon emissions from deforestation in Brazilian Amazonia, contributing to climate change mitigation and forest conservation while distributing benefits for local people, according to Paulo Moutinho, a scientist from IPAM. He adds, Brazilian society is ready and waiting to adopt a REDD program.

In Reducing CO2 emissions from deforestation and forest degradation in the Democratic Republic of the Congo, prepared by the WHRC, a very different forest is analyzed. CO2 emissions from the DRC are low and driven primarily by small-scale farmers, but emissions could escalate rapidly in the future as political stability opens the door to foreign investments and migration. A nationwide assessment of forest carbon stocks and farm family density provides the basis for preliminary estimates of the costs of cutting deforestation by half. When semi-subsistence farmers clear a half-hectare of forest each year to grow the crops that sustain their families, the costs of slowing deforestation must provide for alternative incomes. It will be more expensive to slow emissions from the DRC than from the Brazilian Amazon. However, investments in the management of the timber concession program could provide an important economic incentive to maintain forests standing while generating impo
'/>"/>

Contact: Elizabeth Braun
ebraun@whrc.org
508-540-9900
Woods Hole Research Center
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Toxic releases down from North American industry leaders, increasing from other facilities
2. University of Minnesota releases first ever comprehensive report of the health of college students
3. BIO-key Reports Second Quarter 2007 Results
4. Communication Intelligence Corporation Reports Second Quarter 2007 Financial Results
5. Emory paleontologist reports discovery of carnivorous dinosaur tracks in Australia
6. BIO-key Reports Third Quarter 2007 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...halogram (EEG) is widely used by physicians and sc...eurological disorders. However, it has remained la...ive an exact view of what is happening inside the ...Biological Cybernetics in Tbingen, Germany, have n...ated within the brain to that measured with EEG. T...
(Date:12/4/2009)...ery is challenging accepted thinking about amyloid...seases such as Alzheimer,s and Parkinson,s and ma..., It was believed that amyloid fibrils - rope-lik...s fibres - are inert, but that there may be toxic ...ls and cause disease. , But in a paper publishe...
(Date:12/3/2009)... learn new information and adapt to changes in our...memories, appears to lie in the minute junctions w...tudy by NYU Langone Medicine Center researchers. T...nal Nature . , The scientists, led by Wen-Biao...euroscience at NYU School of Medicine, discovered ...
Breaking Biology News(10 mins):How to read brain activity? 2New therapy targets for amyloid disease 2Lifelong memories linked to stable nerve connections 2Circle Medical Devices Texcel Medical Merge to Form CIRTEC Medical Systems 5558 1Circle Medical Devices Texcel Medical Merge to Form CIRTEC Medical Systems 5558 2Transave Completes Successful Phase II Clinical Program for ARIKACE in the Treatment of Pseudomonas Lung Infections 5556 1Transave Completes Successful Phase II Clinical Program for ARIKACE in the Treatment of Pseudomonas Lung Infections 5556 2Transave Completes Successful Phase II Clinical Program for ARIKACE in the Treatment of Pseudomonas Lung Infections 5556 3Transave Completes Successful Phase II Clinical Program for ARIKACE in the Treatment of Pseudomonas Lung Infections 5556 4Transave Completes Successful Phase II Clinical Program for ARIKACE in the Treatment of Pseudomonas Lung Infections 5556 5Three Cetaphil 28R 29 Products Earn Good Housekeeping Seal 5554 1Three Cetaphil 28R 29 Products Earn Good Housekeeping Seal 5554 2
...the United Kingdom are reporting new evidence that...e material formed when aspirin breaks down in the ...ned effects in relieving pain and inflammation, ma...cording to a study scheduled for the Dec. 24 issue...d Chemistry . , In the report, Gwendoline Baxter,...
...discovered an entirely new mechanism for making co...nding could lead to lasers that operate more effic...vices, and find applications in environmental moni...y provides a new insight into the physics of laser... an electrical engineer, is the director of the Mi...
...eport demonstrates how a sensitive imaging techniq...bacteria in chronic infections. , Listeria monoc... cause severe illness and death. Listeria outbrea...onally, Listeria infection is the third most commo...an cause abortion and stillbirth. When the infect...
Other Biology News:Princeton researchers discover new type of laser 2Princeton researchers discover new type of laser 3New research lights up chronic bacterial infection inside bone 2
(Date:12/2/2009)..., , NEW YORK, Dec. 2 /PRNewswire/ -...earch report is available in its catalogue: ,, ...Market Trends & Opportunities ,, http://w...logies---A-Global-Update-of-Market-Trends--Opportu...tegral and ongoing element of every pharmaceutical...
(Date:12/2/2009)..., , CALGARY, Dec. 2 /PRNewswire-Fi...r the "Company") (TSX:ONC; NASDAQ: ONCY ) announce...ounced unit offering, the underwriters have exerci...sed an additional 637,500 units. Each unit is comp...e purchase warrant, and was sold at a price of US$...
(Date:12/2/2009)..., , JERUSALEM, Israel, Decembe...feasibility study evaluating the preclinical (anim...oduct which combines technology from Weill,Cornell...have potential to,treat inherited anemias such as ...ing a series of technologies to expand, ex vivo,p...
(Date:12/2/2009)..., , QUEBEC CITY, Dec. 2 /PRNewswire-First...: AEZ) (the "Company"), a global biopharmaceutical..., today announced that the U.S. Food and Drug Admi...n for the Company,s PI3K/Akt pathway inhibitor com... relapsed/refractory multiple myeloma. Keryx Bioph...
Breaking Biology Technology:Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3
...r, I commented on the growing generic pharmaceutic...eric pharmaceuticals are not only big business but...ple reasons why: , , 1) Numerous drug patents ex...creased concern in the U.S. about rising drug pric...he U.S. who have no medical insurance and the grow...
...nnovation Network (WIN) Foundation has created a m...t high-tech regions, the Chippewa Valley. , ,The ... Wisconsin Technology Council, which is the indepe...o the Governor and the Legislature. With existing ...nsin, WIN is a networking group aimed at entrepren...
...ent and proud history of interstate sports rivalri...st states). Sometimes, like this past New Years Da...t do the Michigan Wolverines and marijuana have in...idwest states may be fomenting another interstate ...eurs. , ,Earlier this month, Michigans state gove...
Other Biology Technology:The Coming of Biotech Generic Pharmaceuticals 2The Coming of Biotech Generic Pharmaceuticals 3The Coming of Biotech Generic Pharmaceuticals 4WIN Launches Chippewa Valley Chapter 2For Now, Michigan Can Celebrate $150 Million Entrepreneurial VC Fund 2For Now, Michigan Can Celebrate $150 Million Entrepreneurial VC Fund 3For Now, Michigan Can Celebrate $150 Million Entrepreneurial VC Fund 4
MSC.12 class II safety cabinet (Type A1 : recirculated) - BS 5726 (230V / 50Hz) from Thermo Scientific
Rabbit Anti-CHIP Polyclonal Antibody, Unconjugated from Abcam
...two mature, well-understood technologies: grating-...rfaces. This combination produces a sensitive and ...ar binding events without the use of fluorescent l...re immobilized on the dotLab Sensor surface in eig...
...N NGGC3' 3'CGGN NNNNCCG5' Inactivation Conditions:...atment followed by ethanol precipitation. Storage ...mM EDTA, 1.0mM DTT, 0.01% BSA, 50% glycerol. Shipp.... Unit Definition: One unit is defined as the amou...
Biology Products: